TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+33.79%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$527M
AUM Growth
+$527M
(-8%)
Cap. Flow
-$58.2M
Cap. Flow
% of AUM
-11.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Nurix Therapeutics
NRIX
|
$30M |
| 2 |
Fulcrum Therapeutics
FULC
|
$28.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $152M | 28.85% |
5,524,031
| – | – |
|
|
2
Fulcrum Therapeutics
FULC
$351M
| $140M | 26.57% |
4,962,202
-1,000,000
| -17% | -$28.2M |
|
3
Pliant Therapeutics
PLRX
$101M
| $98.6M | 18.71% |
5,839,160
| – | – |
|
|
4
Nurix Therapeutics
NRIX
$714M
| $72.6M | 13.78% |
2,422,549
-1,000,000
| -29% | -$30M |
|
|
DBTX
5
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $24.2M | 4.6% |
3,139,685
| – | – |
|
|
JNCE
6
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $22.7M | 4.3% |
3,048,780
| – | – |
|
7
Voyager Therapeutics
VYGR
$186M
| $16.8M | 3.19% |
6,391,176
| – | – |
|